Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors

Clinical and Experimental Metastasis

Volumn 30, Issue 6, 2013, Pages 723-729

  Nieder, Carsten ^a,b   Norum, Jan ^b,c,d   Dalhaug, Astrid ^a,b   Aandahl, Gro ^a   Pawinski, Adam ^a  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d NORTHERN NORWAY REGIONAL HEALTH AUTHORITY   (Norway)

Author keywords

Best supportive care; Brain metastases; Prognostic factors; Radiotherapy

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; BEST SUPPORTIVE CARE; BRAIN METASTASIS; BREAST CANCER; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PATIENT CARE; PRIMARY TUMOR; RADIATION DOSE; TREATMENT RESPONSE;

AGED; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84887090203     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9573-x     Document Type: Article

References (17)

1. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhart R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751
2. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510-514
3. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655-661
4. Horton J, Baxter DH, Olson KB (1971) The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol 111:334-336
5. Langley RE, Stephens RJ, Nankivell M, Pugh C, Moore B, Navani N, Wilson P, Faivre-Finn C, Barton R, Parmar M, Mulvenna PM (2012) Interim data from the medical research council QUARTZ trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol) Epub ahead of print 2012 Dec 1
6. Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H (2010) Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 117:2505-2512
7. Nieder C, Norum J, Stemland JG, Dalhaug A (2010) Resource utilization in patients with brain metastases managed with best supportive care, radiotherapy and/or surgical resection: a Markov analysis. Oncology 78:348-355
8. Nieder C, Grosu AL, Spanne O, Andratschke NH, Geinitz H (2012) Brain metastases in patients under 50 years of age: retrospective analysis. Clin Exp Metastasis 29:949-956
9. Tarhan MO, Demir L, Somali I, Yigit S, Erten C, Alacacioglu A, Ellidokuz H, Seseogullari O, Kucukzeybek Y, Can A, Dirican A, Bayoglu V, Akyol M (2013) The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival. Clin Exp Metastasis 30(2):201-213
10. Bleckmann A, Siam L, Klemm F, Rietkötter E, Wegner C, Kramer F, Beissbarth T, Binder C, Stadelmann C, Pukrop T (2012) Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas. Clin Exp Metastasis 2012 Dec 8 (Epub ahead of print)
11. Rades D, Evers JN, Veninga T, Stalpers LJ, Lohynska R, Schild SE (2011) Shorter-course whole-brain radiotherapy for brain metastases in elderly patients. Int J Radiat Oncol Biol Phys 81:e467-e473
12. Nieder C, Marienhagen K, Dalhaug A, Norum J (2012) Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels. Sci World J 2012:609323
13. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795-803
14. Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH (2002) Survival by Radiation Therapy Oncology Group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 94:2265-2272
15. Farnell GF, Buckner JC, Cascino TL, O'Connell MJ, Schomberg PJ, Suman V (1996) Brain metastases from colorectal carcinoma the long term survivors. Cancer 78:711-716
16. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF (2004) Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22:1293-1300
17. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419-425